Navigation Links
Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)
Date:9/3/2008

NEW YORK, Sept. 3 /PRNewswire/ -- Concentric Pharma Advertising, one of the fastest growing marketing agencies in the healthcare field, has been named agency of record by Discovery Labs for SURFAXIN(R) (lucinactant), an investigational drug being reviewed by the Food and Drug Administration for the treatment of respiratory distress syndrome (RDS) in newborns.

"We selected Concentric for this assignment because the company's strategic insight and creative vision best captured the essence of the SURFAXIN brand," said John Wilson, vice president of sales and marketing at Discovery, adding that the agency's in-depth knowledge of neonatology and acute RDS in premature infants also played a significant part in the decision.

The full-service U.S. assignment will include a wide range of activities, including corporate and product branding, positioning, and the creation of support materials geared to neonatologists, neonatal intensive care unit (NICU) nurses, respiratory therapists, hospital pharmacists, and, potentially, parents of newborns. The agency's account team will be led by Ed Mutch, account supervisor. Blake Benner, director of marketing at Discovery Labs, will manage the account on the client side.

Discovery Labs, headquartered in Warrington, Pa., is a biotechnology company developing novel surfactant replacement therapies (SRTs) with potential for application across the continuum of respiratory diseases, initially focusing on RDS in premature infants.

About Concentric

Concentric Pharma Advertising, an independent healthcare advertising and marketing firm established in 2002, is one of the fastest growing agencies in the healthcare field, enjoying double-digit revenue growth for the fourth year in a row. In the past year alone, the agency won 10 new assignments, launched a new division, expanded its senior management team, and won several awards in prestigious U.S. and global ad competitions.

Concentric offers a wide range of fully integrated marketing services, including professional and DTC advertising, corporate and product branding, sales force education, sales promotion, strategic and tactical planning, digital media, managed markets planning, formulary access programs, relationship marketing, and a full range of patient and consumer education programs. Clients include Alcon Labs, Bayer HealthCare, Cobalt Laboratories, Coria Laboratories, Discovery Labs, Mitsubishi Pharma USA, Neuromed, Pfizer and Wyeth.

Concentric is located at 71 West 23rd St, 9th floor, New York, NY 10010, but will soon be moving into spacious new quarters in lower Manhattan. To learn more, visit http://www.concentric-rx.com , call 212-633-9700, or email info@concentric-rx.com.

CONTACT: Julie Laitin (212) 286-2424 Cynthia Amorese (908) 665-8072

Email: jlaitin@julielaitin.com Email: camorese@comcast.net


'/>"/>
SOURCE Concentric Pharma Advertising
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
2. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
3. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
4. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
9. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
10. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
11. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The Blavatnik Family Foundation and ... Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. Established in ... by the New York Academy of Sciences to honor the excellence of outstanding ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global ... industries to improve patient outcomes and quality of life, will now be offering ... being attributed to new regulatory requirements for all new drug products, including the ...
(Date:10/11/2017)... ... ... wash is a basic first aid supply for any work environment, but most personal eye ... first if a dangerous substance enters both eyes? It’s one less decision, and likely quicker ... eye piece. , “Whether its dirt and debris, or an acid or alkali, getting anything ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):